301 related articles for article (PubMed ID: 30745845)
21. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW
Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103
[TBL] [Abstract][Full Text] [Related]
22. m
Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y
J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068
[TBL] [Abstract][Full Text] [Related]
23. TRIB3-Regulated Akt Signal Pathway Affects Trophoblast Invasion in the Development of Preeclampsia.
Sui X; Zhang L; Zhang XF; Zhang Y
Am J Perinatol; 2023 Sep; 40(12):1359-1366. PubMed ID: 34553361
[TBL] [Abstract][Full Text] [Related]
24. TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity.
Wennemers M; Bussink J; Grebenchtchikov N; Sweep FC; Span PN
Radiother Oncol; 2011 Oct; 101(1):198-202. PubMed ID: 21704407
[TBL] [Abstract][Full Text] [Related]
25. TRIB3 destabilizes tumor suppressor PPARα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
Luo X; Zhong L; Yu L; Xiong L; Dan W; Li J; Ye J; Chu X; Liu C; Liu B
Life Sci; 2020 Sep; 257():118021. PubMed ID: 32621919
[TBL] [Abstract][Full Text] [Related]
26. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
[TBL] [Abstract][Full Text] [Related]
27. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
[TBL] [Abstract][Full Text] [Related]
28. Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.
Mondal D; Mathur A; Chandra PK
Biochimie; 2016 May; 124():34-52. PubMed ID: 26855171
[TBL] [Abstract][Full Text] [Related]
29. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
[TBL] [Abstract][Full Text] [Related]
30. Tribble 3, a novel oxidized low-density lipoprotein-inducible gene, is induced via the activating transcription factor 4-C/EBP homologous protein pathway.
Shang YY; Zhong M; Zhang LP; Guo ZX; Wang ZH; Zhang Y; Deng JT; Zhang W
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):51-5. PubMed ID: 19566842
[TBL] [Abstract][Full Text] [Related]
31. Circ-APBB1IP as a Prognostic Biomarker Promotes Clear Cell Renal Cell Carcinoma Progression Through The ERK1/2 Signaling Pathway.
Mo J; Zhao Y; Ao Z; Chen L; Lin S; Zeng W; Wu H; Liu J
Int J Med Sci; 2020; 17(9):1177-1186. PubMed ID: 32547313
[TBL] [Abstract][Full Text] [Related]
32. The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases.
Prudente S; Sesti G; Pandolfi A; Andreozzi F; Consoli A; Trischitta V
Endocr Rev; 2012 Aug; 33(4):526-46. PubMed ID: 22577090
[TBL] [Abstract][Full Text] [Related]
33. Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer.
Zhou W; Ma J; Meng L; Liu D; Chen J
BMC Cancer; 2022 Apr; 22(1):459. PubMed ID: 35473511
[TBL] [Abstract][Full Text] [Related]
34. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
[TBL] [Abstract][Full Text] [Related]
35. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
[TBL] [Abstract][Full Text] [Related]
36. TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.
Zhou S; Liu S; Lin C; Li Y; Ye L; Wu X; Jian Y; Dai Y; Ouyang Y; Zhao L; Liu M; Song L; Xi M
Oncogene; 2020 Apr; 39(18):3710-3725. PubMed ID: 32157210
[TBL] [Abstract][Full Text] [Related]
37. TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway.
Shen P; Zhang TY; Wang SY
Exp Ther Med; 2021 Apr; 21(4):313. PubMed ID: 33717256
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of TRIB3 promotes angiogenesis in human gastric cancer.
Dong S; Xia J; Wang H; Sun L; Wu Z; Bin J; Liao Y; Li N; Liao W
Oncol Rep; 2016 Oct; 36(4):2339-48. PubMed ID: 27573078
[TBL] [Abstract][Full Text] [Related]
39. TRIB3 downregulation enhances doxorubicin-induced cytotoxicity in gastric cancer cells.
Wu IJ; Lin RJ; Wang HC; Yuan TM; Chuang SM
Arch Biochem Biophys; 2017 May; 622():26-35. PubMed ID: 28442401
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer.
Felip I; Moiola CP; Megino-Luque C; Lopez-Gil C; Cabrera S; Solé-Sánchez S; Muñoz-Guardiola P; Megias-Roda E; Pérez-Montoyo H; Alfon J; Yeste-Velasco M; Santacana M; Dolcet X; Reques A; Oaknin A; Rodríguez-Freixinos V; Lizcano JM; Domènech C; Gil-Moreno A; Matias-Guiu X; Colas E; Eritja N
Gynecol Oncol; 2019 May; 153(2):425-435. PubMed ID: 30853360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
